Similar articles

• A dose-finding study of methylene blue to inhibit nitric oxide actions in the hemodynamics of human septic shock.

  Juffermans NP, Vervloet MG, Daemen-Gubbels CR, Binnekade JM, de Jong M, Groeneveld AB. Juffermans NP, et al. Nitric Oxide. 2010 May 15;22(4):275-80. doi: 10.1016/j.niox.2010.01.006. Epub 2010 Jan 28. Nitric Oxide. 2010. PMID: 20109575 Clinical Trial.
• [Inhibition of the nitric oxide pathway in refractory septic shock].

  Andresen M, Dougnac A, Hernández G, Espejo J, Castillo L, Bugedo G, Letelier LM, Dagnino J. Andresen M, et al. Rev Med Chil. 1996 Apr;124(4):442-7. Rev Med Chil. 1996. PMID: 9110484 Spanish.
• Methylene blue for the treatment of septic shock.

  Paciullo CA, McMahon Horner D, Hatton KW, Flynn JD. Paciullo CA, et al. Pharmacotherapy. 2010 Jul;30(7):702-15. doi: 10.1592/phco.30.7.702. Pharmacotherapy. 2010. PMID: 20575634 Review.
• Prolonged methylene blue infusion in refractory septic shock: a case report.

  Dumbarton TC, Minor S, Yeung CK, Green R. Dumbarton TC, et al. Can J Anaesth. 2011 Apr;58(4):401-5. doi: 10.1007/s12630-011-9458-x. Epub 2011 Jan 19. Can J Anaesth. 2011. PMID: 21246318
• [Nitric oxide--an important mediator in sepsis?].

  Kirkebøen KA, Strand OA. Kirkebøen KA, et al. Tidsskr Nor Laegeforen. 1999 Nov 10;119(27):4061-5. Tidsskr Nor Laegeforen. 1999. PMID: 10613098 Review. Norwegian.